Health Secretary Robert F. Kennedy Jr. said on May 14 that he has ordered the Food and Drug Administration (FDA) to complete a review of the abortion pill mifepristone.
Sen. Josh Hawley (R-Mo.), during a hearing in Washington, highlighted an analysis of insurance claims that found 11 percent of women who took the drug experienced serious adverse events, a percentage far higher than the reported rate of under 0.5 percent among clinical trial participants.
